Disclosed is a use of a conjugate of Formula I [177Lu] - R1 - R2 - R3 (I) wherein R1 is a metal chelator suitable for chelating [177Lu], R2 is a spacer linked to N-terminal of R3 or a covalent bond, R3 is a bombesin analog peptide antagonist of sequence from seq 1 to 4, Seq 1: D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2; Seq 2: D-Phe-Gln-Trp-Ala-Val-Gly-His-LeuѰ (CHOH-CH2)-(CH2) 2-CH3; Seq 3: D-Phe-Gln-Trp-Ala-Val-Gly-His-LeuѰ(CH2NH)-Phe-NH2; and Seq 4: D-Phe-Gln-Trp-Ala-Val-Gly-His-LeuѰ (CH2NH)-Cys-NH2. and pharmaceutically acceptable salts thereof, in the manufacture of a medicament for the treatment of tumors.